Also dba as Woodland Biosciences, Woodland Pharmaceuticals personnel have expertise in metabolic liver disease and cancer. With a focus in oncology and the physiological dysfunctions predisposing to cancers, Woodland Pharmaceuticals is a preclinical contract research organization (CRO) offering in vivo, preclinical, efficacy modeling services With the stated mission being improvement of laboratory modeling of refractory drug resistant human cancers, the firm's research capabilities cover the spectrum of anti-cancer research from in vitro lead optimization up through complex animal modeling of PK/PD and efficacy studies, leading directly to primary tumor models designed to improve clinical success.
